Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hysan Pflegespray (hysan® Pflegespray) is a nasal medical device developed and marketed by URSAPHARM Arzneimittel GmbH for the treatment of dry nose (rhinitis sicca) and as adjunctive therapy for various forms of rhinitis and rhinosinusitis. It is a sterile, preservative-free solution containing a combination of sodium hyaluronate and dexpanthenol. Sodium hyaluronate acts as a humectant by binding water and forming a stable moisture film on the nasal mucosa, providing long-lasting hydration. Dexpanthenol (provitamin B5) supports the regeneration and healing of the mucosal tissue. The product is administered intranasally and is suitable for adults, children, and pregnant or breastfeeding women.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium hyaluronate + dexpanthenol (URSAPHARM).